SG11201708140RA - Novel pyridinium compounds - Google Patents

Novel pyridinium compounds

Info

Publication number
SG11201708140RA
SG11201708140RA SG11201708140RA SG11201708140RA SG11201708140RA SG 11201708140R A SG11201708140R A SG 11201708140RA SG 11201708140R A SG11201708140R A SG 11201708140RA SG 11201708140R A SG11201708140R A SG 11201708140RA SG 11201708140R A SG11201708140R A SG 11201708140RA
Authority
SG
Singapore
Prior art keywords
pyridinium compounds
novel pyridinium
novel
compounds
pyridinium
Prior art date
Application number
SG11201708140RA
Inventor
Chaitanya Dutt
Rameshchandra Gupta
Manish Patel
Jaya Abraham
Vivek Mishra
Amit Kesarwani
Shailesh Deshpande
Shital Kumar Zambad
Anoop Mathur
Jignesh Kotecha
Sachin Latad
Anita Chaudhari
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of SG11201708140RA publication Critical patent/SG11201708140RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
SG11201708140RA 2015-04-08 2016-04-05 Novel pyridinium compounds SG11201708140RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1473MU2015 2015-04-08
PCT/IB2016/051917 WO2016162785A1 (en) 2015-04-08 2016-04-05 Novel pyridinium compounds

Publications (1)

Publication Number Publication Date
SG11201708140RA true SG11201708140RA (en) 2017-11-29

Family

ID=55808799

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201708140RA SG11201708140RA (en) 2015-04-08 2016-04-05 Novel pyridinium compounds

Country Status (19)

Country Link
US (2) US10233175B2 (en)
EP (1) EP3280711A1 (en)
JP (1) JP6782763B2 (en)
KR (1) KR20170134661A (en)
CN (1) CN107438604B (en)
AR (1) AR104274A1 (en)
AU (1) AU2016245418B2 (en)
BR (1) BR112017021631A2 (en)
CA (1) CA2997364A1 (en)
EA (1) EA035406B1 (en)
IL (1) IL254792B (en)
MX (1) MX2017012943A (en)
MY (1) MY182914A (en)
PH (1) PH12017501830A1 (en)
SG (1) SG11201708140RA (en)
TW (1) TWI710559B (en)
UA (1) UA120389C2 (en)
WO (1) WO2016162785A1 (en)
ZA (1) ZA201707090B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107438604B (en) * 2015-04-08 2021-12-03 托伦特药物有限公司 Novel pyridine compound
MA54133B1 (en) 2018-03-08 2022-01-31 Incyte Corp Aminopyrazine diol compounds used as pi3k-y inhibitors
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
US20200338058A1 (en) * 2019-04-28 2020-10-29 King Faisal University Therapeutic agents for treating and preventing autoimmune diseases and cancer and a screening method
WO2022238921A1 (en) * 2021-05-14 2022-11-17 Torrent Pharmaceuticals Limited In-situ synthesis of 3-substituted pyridinium compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608094B2 (en) * 1999-10-06 2003-08-19 Torrent Pharmaceuticals Ltd. Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
EP1222171B1 (en) * 1999-10-06 2004-02-25 Torrent Pharmaceuticals Ltd Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
JP2003511370A (en) * 1999-10-06 2003-03-25 トレント・ファーマシューティカルズ・リミテッド Compounds for the treatment of vascular complications associated with diabetes and aging
ES2243389T3 (en) 2001-03-21 2005-12-01 Torrent Pharmaceuticals Ltd PIRIDINUM COMPOUNDS USEFUL FOR THE TREATMENT OF AGE-RELATED DISEASES.
ES2231685T3 (en) 2001-04-05 2005-05-16 Torrent Pharmaceuticals Ltd HETEROCICLICAL COMPOUNDS FOR DIABETIC VASCULAR COMPLICATIONS AND RELATED TO AGE.
WO2007100295A1 (en) 2006-03-03 2007-09-07 Torrent Pharmaceuticals Ltd Novel dual action receptors antagonists (dara) at the ati and eta receptors
CN107438604B (en) * 2015-04-08 2021-12-03 托伦特药物有限公司 Novel pyridine compound

Also Published As

Publication number Publication date
TW201639834A (en) 2016-11-16
JP6782763B2 (en) 2020-11-11
MX2017012943A (en) 2018-01-30
EA035406B1 (en) 2020-06-09
EP3280711A1 (en) 2018-02-14
US10233175B2 (en) 2019-03-19
CN107438604B (en) 2021-12-03
BR112017021631A2 (en) 2018-07-03
IL254792B (en) 2021-01-31
IL254792A0 (en) 2017-12-31
AU2016245418B2 (en) 2020-03-26
KR20170134661A (en) 2017-12-06
WO2016162785A1 (en) 2016-10-13
EA201792234A1 (en) 2018-02-28
AU2016245418A1 (en) 2017-11-02
MY182914A (en) 2021-02-05
US20190169175A1 (en) 2019-06-06
UA120389C2 (en) 2019-11-25
US10717727B2 (en) 2020-07-21
AR104274A1 (en) 2017-07-12
CA2997364A1 (en) 2016-10-13
JP2018511658A (en) 2018-04-26
TWI710559B (en) 2020-11-21
PH12017501830A1 (en) 2018-04-23
US20180118728A1 (en) 2018-05-03
CN107438604A (en) 2017-12-05
ZA201707090B (en) 2021-03-31

Similar Documents

Publication Publication Date Title
HK1256059A1 (en) Novel compounds
HK1243410A1 (en) Novel compounds
GB201521109D0 (en) Novel compounds
GB201516243D0 (en) Novel compounds
GB201522768D0 (en) Novel compounds
GB201506871D0 (en) Novel compounds
GB201501462D0 (en) Novel compounds
GB201522179D0 (en) Novel compounds
GB201504565D0 (en) Novel compounds
GB201508747D0 (en) Compounds
ZA201707090B (en) Novel pyridinium compounds
GB201520500D0 (en) Compounds
GB201508864D0 (en) Compounds
IL253813A0 (en) Diaza-benzofluoranthrene compounds
ZA201701783B (en) Pyridine compounds
GB201502675D0 (en) Novel compounds
LT3331885T (en) Compounds
GB201508857D0 (en) Compounds
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
GB201521749D0 (en) Novel compounds
GB201521713D0 (en) Novel compounds
GB201516241D0 (en) Novel compounds
GB201512829D0 (en) Novel compounds
GB201512270D0 (en) Novel Compounds